2 results
Approved WMOPending
Assess whether APL180 can improve endothelial function in patients with Familial hypercholesterolemia
Approved WMOCompleted
The aim of this phase IVI, randomized, open-label study is to compare the efficacy of cabazitaxel versus an AR targeted agent, in patients previously treated with docetaxel and likely to have primary resistance to AR targeted agents.